{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T10:28:15Z","timestamp":1794479295951,"version":"4.9.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Secretar\u00eda de Ciencia, Humanidades, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["CB-282663"],"award-info":[{"award-number":["CB-282663"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Secretar\u00eda de Ciencia, Humanidades, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["CBF-2023\\u20132024\\u20132740"],"award-info":[{"award-number":["CBF-2023\\u20132024\\u20132740"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Secretar\u00eda de Ciencia, Humanidades, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["CF-2023-I-1738"],"award-info":[{"award-number":["CF-2023-I-1738"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007161","name":"Secretar\u00eda de Investigaci\u00f3n y Posgrado, Instituto Polit\u00e9cnico Nacional","doi-asserted-by":"publisher","award":["20240460"],"award-info":[{"award-number":["20240460"]}],"id":[{"id":"10.13039\/501100007161","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.biopha.2026.119490","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:36:27Z","timestamp":1778621787000},"page":"119490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discovery of 4-carboxylate-1,2,3-triazine 1-oxide, their 1,2,3-triazine, and the 3,6-dihydro analogs, as new agents against Chagas diseases and Leishmaniasis"],"prefix":"10.1016","volume":"199","author":[{"given":"Diana V.","family":"Navarrete-Carriola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel J.","family":"Chan-Bacab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Quintero-Solano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"S\u00e1nchez-Palestino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyra","family":"Ortiz-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario A.","family":"Bautista-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Moreno-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Mendoza-Conde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Citlali","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Saavedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9842-4167","authenticated-orcid":false,"given":"Gildardo","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119490_bib1","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0140-6736(16)30171-4","article-title":"Neglected tropical diseases: progress towards addressing the chronic pandemic","volume":"389","author":"Molyneux","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2026.119490_bib2","unstructured":"WHO. Neglected Topical Diseases. Neglected tropical diseases -- GLOBAL. (2024)."},{"issue":"9","key":"10.1016\/j.biopha.2026.119490_bib3","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/tmi.13915","article-title":"Oral transmission of Chagas disease from a One Health approach: a systematic review","volume":"28","author":"L\u00f3pez-Garc\u00eda","year":"2023","journal-title":"Trop. Med Int Health"},{"key":"10.1016\/j.biopha.2026.119490_bib4","unstructured":"WHO. Chagas Disease (American Trypanosomiasis). Chagas disease (also known as American trypanosomiasis) (2024)."},{"issue":"7","key":"10.1016\/j.biopha.2026.119490_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taz060","article-title":"Chagas disease: comments on the 2018 PAHO Guidelines for diagnosis and management","volume":"26","author":"Norman","year":"2019","journal-title":"J. Travel Med"},{"issue":"1","key":"10.1016\/j.biopha.2026.119490_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5334\/gh.1150","article-title":"Regional, and National trends of chagas disease from 1990 to 2019: comprehensive analysis of the global burden of disease study","volume":"17","author":"G\u00f3mez-Ochoa","year":"2022","journal-title":"Glob. Heart"},{"key":"10.1016\/j.biopha.2026.119490_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112020","article-title":"Advances in the treatment of Chagas disease: promising new drugs, plants, and targets","volume":"142","author":"Garcia-Huertas","year":"2021","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2026.119490_bib8","doi-asserted-by":"crossref","first-page":"750","DOI":"10.12688\/f1000research.11120.1","article-title":"Leishmaniasis: a review","volume":"6","author":"Torres-Guerrero","year":"2017","journal-title":"F1000Research"},{"issue":"5","key":"10.1016\/j.biopha.2026.119490_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis control team. Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biopha.2026.119490_bib10","first-page":"365","article-title":"Urbanization: An increasing risk factor for leishmaniasis","volume":"77","author":"WHO","year":"2002"},{"issue":"1","key":"10.1016\/j.biopha.2026.119490_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/clinids\/22.1.1","article-title":"Clinical spectrum of leishmaniasis","volume":"22","author":"Pearson","year":"1996","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.biopha.2026.119490_bib12","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.4269\/ajtmh.17-0736","article-title":"The elderly responds to antimony therapy for cutaneous leishmaniasis similarly to young patients but have severe adverse reactions","volume":"98","author":"Lago","year":"2018","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"1","key":"10.1016\/j.biopha.2026.119490_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106459","article-title":"An update on the clinical pharmacology of miltefosine in the treatment of leishmaniasis","volume":"59","author":"Pali\u0107","year":"2022","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"10","key":"10.1016\/j.biopha.2026.119490_bib14","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1080\/14656566.2019.1609940","article-title":"Current and emerging medications for the treatment of leishmaniasis","volume":"20","author":"Chakravarty","year":"2019","journal-title":"Expert Opin. Pharm."},{"key":"10.1016\/j.biopha.2026.119490_bib15","unstructured":"WHO. Leishmaniasis. Leishmaniasis. (2023)."},{"issue":"21","key":"10.1016\/j.biopha.2026.119490_bib16","doi-asserted-by":"crossref","first-page":"8965","DOI":"10.1007\/s00253-020-10856-w","article-title":"Recent advances and new strategies on leishmaniasis treatment","volume":"104","author":"Roatt","year":"2020","journal-title":"Appl. Microbiol Biotechnol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119490_bib17","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.bbagen.2008.03.006","article-title":"Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism","volume":"1780","author":"Krauth-Siegel","year":"2008","journal-title":"Biochim Biophys. Acta"},{"issue":"1","key":"10.1016\/j.biopha.2026.119490_bib18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0969-2126(99)80011-2","article-title":"Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors","volume":"7","author":"Bond","year":"1999","journal-title":"Structure"},{"issue":"8","key":"10.1016\/j.biopha.2026.119490_bib19","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.3390\/molecules25081924","article-title":"Targeting trypanothione reductase, a key enzyme in the redox trypanosomatid metabolism, to develop new drugs against leishmaniasis and trypanosomiases","volume":"25","author":"Battista","year":"2020","journal-title":"Molecules"},{"issue":"24","key":"10.1016\/j.biopha.2026.119490_bib20","doi-asserted-by":"crossref","first-page":"10257","DOI":"10.1021\/jm501100b","article-title":"Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals","volume":"57","author":"Vitaku","year":"2014","journal-title":"J. Med Chem."},{"issue":"10","key":"10.1016\/j.biopha.2026.119490_bib21","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1021\/acs.jmedchem.5b01409","article-title":"Analysis of past and present synthetic methodologies on medicinal chemistry: where have all the new reactions gone?","volume":"59","author":"Brown","year":"2016","journal-title":"J. Med Chem."},{"issue":"72","key":"10.1016\/j.biopha.2026.119490_bib22","doi-asserted-by":"crossref","first-page":"44247","DOI":"10.1039\/D0RA09198G","article-title":"Prescribed drugs containing nitrogen heterocycles: an overview","volume":"10","author":"Heravi","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.biopha.2026.119490_bib23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2174\/1389557513666140103111017","article-title":"1,2,3-Triazine scaffold as a potent biologically active moiety: a mini review","volume":"14","author":"Kumar","year":"2014","journal-title":"Mini Rev. Med Chem."},{"issue":"3","key":"10.1016\/j.biopha.2026.119490_bib24","first-page":"310","article-title":"Pharmacological overview and recent patent of triazine scaffold in drug development: a review","volume":"22","author":"Pragya","year":"2024","journal-title":"Curr. Org. Synth."},{"issue":"11","key":"10.1016\/j.biopha.2026.119490_bib25","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1021\/jm0402014","volume":"48","author":"Migawa","year":"2005","journal-title":"J. Med. Chem."},{"issue":"43","key":"10.1016\/j.biopha.2026.119490_bib26","doi-asserted-by":"crossref","first-page":"30462","DOI":"10.1039\/D3RA05953G","article-title":"Recent biological applications of heterocyclic hybrids containing s-triazine scaffold","volume":"13","author":"Ali","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.biopha.2026.119490_bib27","unstructured":"DRUGBANK. Melarsoprol. \u3008https:\/\/go.drugbank.com\/drugs\/DB12864\u3009. (2021)."},{"issue":"11","key":"10.1016\/j.biopha.2026.119490_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00311-21","article-title":"The novel bis-1,2,4-Triazine MIPS-0004373 demonstrates rapid and potent activity against all blood stages of the malaria parasite","volume":"65","author":"Ellis","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"issue":"16","key":"10.1016\/j.biopha.2026.119490_bib29","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1021\/acs.orglett.1c02352","article-title":"Intermolecular [5 + 1]-Cycloaddition between Vinyl Diazo compounds and tert-butyl nitrite to 1,2,3-triazine 1-oxides and their further transformation to isoxazoles","volume":"23","author":"De Angelis","year":"2021","journal-title":"Org. Lett."},{"issue":"24","key":"10.1016\/j.biopha.2026.119490_bib30","doi-asserted-by":"crossref","first-page":"13059","DOI":"10.1021\/jacs.3c01347","article-title":"Site reversal in nucleophilic addition to 1,2,3-triazine 1-oxides","volume":"145","author":"De Angelis","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"36","key":"10.1016\/j.biopha.2026.119490_bib31","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.1021\/acs.orglett.2c02484","article-title":"Synthesis of 1,2,3-triazine derivatives by deoxygenation of 1,2,3-triazine 1-oxides","volume":"24","author":"Rivera","year":"2022","journal-title":"Org. Lett."},{"issue":"2","key":"10.1016\/j.biopha.2026.119490_bib32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1590\/S0074-02762010000200022","article-title":"vitro and in vivo experimental models for drug screening and development for chagas disease","volume":"105","author":"Romanha","year":"2010","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"6","key":"10.1016\/j.biopha.2026.119490_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e28025","article-title":"An in vitro and in silico investigation of the antitrypanosomal activities of the stem bark extracts of Anopyxis klaineana (Pierre) Engl","volume":"10","author":"Adams","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.biopha.2026.119490_bib34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejmech.2019.03.063","article-title":"Synthetic approaches and pharmaceutical applications of chloro-containing molecules for drug discovery: a critical review","volume":"173","author":"Fang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.biopha.2026.119490_bib35","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1021\/acs.jmedchem.4c00254","article-title":"Medicinal chemistry of drugs with N-oxide functionalities","volume":"67","author":"Kobus","year":"2024","journal-title":"J. Med Chem."},{"issue":"8","key":"10.1016\/j.biopha.2026.119490_bib36","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1021\/ja01062a035","article-title":"p-\u03c3-\u03c0 analysis. a method for the correlation of biological activity and chemical structure","volume":"86","author":"Hansch","year":"1964","journal-title":"J. Am. Chem. Soc."},{"issue":"21","key":"10.1016\/j.biopha.2026.119490_bib37","doi-asserted-by":"crossref","first-page":"13315","DOI":"10.3390\/ijms232113315","article-title":"Vitro and in silico analysis of new n-butyl and isobutyl Quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives against Trypanosoma cruzi as trypanothione reductase inhibitors","volume":"23","author":"Gonz\u00e1lez-Gonz\u00e1lez","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119490_bib38","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13104-021-05472-4","article-title":"vitro cytotoxicity of Aspilia pluriseta Schweinf. extract fractions","volume":"14","author":"Njeru","year":"2021","journal-title":"BMC Res Notes"},{"issue":"9","key":"10.1016\/j.biopha.2026.119490_bib39","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.3390\/ijms22094931","article-title":"Effective drug concentration and selectivity depends on fraction of primitive cells","volume":"22","author":"Lica","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119490_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2025.102615","article-title":"The importance of persistence and dormancy in Trypanosoma cruzi infection and Chagas disease","volume":"86","author":"Bunkofske","year":"2025","journal-title":"Curr. Opin. Microbiol"},{"issue":"8","key":"10.1016\/j.biopha.2026.119490_bib41","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1128\/AAC.00520-15","article-title":"Limited ability of posaconazole to cure both acute and chronic trypanosoma cruzi infections revealed by highly sensitive in vivo imaging","volume":"59","author":"Francisco","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2026.119490_bib42","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34039","article-title":"Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure","volume":"7","author":"S\u00e1nchez-Vald\u00e9z","year":"2018","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.biopha.2026.119490_bib43","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s42003-025-08386-0","article-title":"Identification of potent inhibitors of Leishmania donovani and Leishmania infantum chagasi, the causative agents of old and new world visceral leishmaniasis","volume":"8","author":"Zulfiqar","year":"2025","journal-title":"Commun. Biol."},{"key":"10.1016\/j.biopha.2026.119490_bib44","article-title":"Lipophilicity and drug activity","volume":"23","author":"Kubinyi","year":"1979"},{"key":"10.1016\/j.biopha.2026.119490_bib45","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11101-015-9413-5","article-title":"Naturally occurring naphthalenes: chemistry, biosynthesis, structural elucidation, and biological activities","volume":"15","author":"Ibrahim","year":"2015","journal-title":"Phytochem. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2026.119490_bib46","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13321-020-0412-1","article-title":"Craig plot 2.0: an interactive navigation in the substituent bioisosteric space","volume":"12","author":"Ertl","year":"2020","journal-title":"J. Chemin.-."},{"issue":"6","key":"10.1016\/j.biopha.2026.119490_bib47","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/prot.24260","article-title":"\u03c0-\u03c0 stacking mediated drug-drug interactions in human CYP2E1","volume":"81","author":"Liu","year":"2013","journal-title":"Proteins"},{"issue":"8","key":"10.1016\/j.biopha.2026.119490_bib48","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s40262-016-0371-x","article-title":"Quantitative prediction of drug interactions caused by CYP1A2 inhibitors and inducers","volume":"55","author":"Gabriel","year":"2016","journal-title":"Clin. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2026.119490_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/00498254.2019.1648911","article-title":"Cytochrome P450: genotype to phenotype","volume":"50","author":"Waring","year":"2019","journal-title":"Xenobiotica"},{"issue":"11","key":"10.1016\/j.biopha.2026.119490_bib50","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1016\/j.bmcl.2008.05.009","article-title":"Design, synthesis and in vitro antiprotozoal activity of benzimidazole-pentamidine hybrids","volume":"18","author":"Torres-G\u00f3mez","year":"2008","journal-title":"Bioorg. Med Chem. Lett."},{"issue":"6","key":"10.1016\/j.biopha.2026.119490_bib51","first-page":"1292","article-title":"Nitazoxanide, tizoxanide and a new analogue [4-nitro-N-(5-nitro-1,3-thiazol-2-yl)benzamide; NTB] inhibit the growth of kinetoplastid parasites (Trypanosoma cruzi and Leishmania mexicana) in vitro","volume":"63","author":"Chan-Bacab","year":"2009","journal-title":"J. Ant. Chem."},{"key":"10.1016\/j.biopha.2026.119490_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116417","article-title":"In vitro, ex vivo and in vivo short-term screening of DHEA nitrate derivatives activity over Trypanosoma cruzi Ninoa and TH strains from Oaxaca State, M\u00e9xico","volume":"48","author":"Dom\u00ednguez-D\u00edaz","year":"2021","journal-title":"Bioorg. Med Chem."},{"key":"10.1016\/j.biopha.2026.119490_bib53","article-title":"Metabolic control analysis of the trans sulfuration pathway and the compensatory role of the cysteine transport in Trypanosoma cruzi","volume":"234","author":"V\u00e1zquez","year":"2023","journal-title":"Bio Syst."},{"issue":"10","key":"10.1016\/j.biopha.2026.119490_bib54","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1111\/j.1742-4658.2012.08557.x","article-title":"Drug target validation of the trypanothione pathway enzymes through metabolic modelling","volume":"279","author":"Olin-Sandoval","year":"2012","journal-title":"FEBS J."},{"issue":"2","key":"10.1016\/j.biopha.2026.119490_bib55","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbagen.2014.10.029","article-title":"Metabolic control analysis of the Trypanosoma cruzi peroxide detoxification pathway identifies tryparedoxin as a suitable drug target","volume":"1850","author":"Gonz\u00e1lez-Ch\u00e1vez","year":"2015","journal-title":"Biochim Biophys. Acta"},{"issue":"3","key":"10.1016\/j.biopha.2026.119490_bib56","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0001-706X(97)00131-9","article-title":"Biological characterization and genetic diversity of Mexican isolates of Trypanosoma cruzi","volume":"69","author":"L\u00f3pez-Olmos","year":"1998","journal-title":"Acta Trop."},{"key":"10.1016\/j.biopha.2026.119490_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116307","article-title":"Microencapsulation of theobroma cacao L polyphenols: a high-value approach with in vitro anti-Trypanosoma cruzi, immunomodulatory and antioxidant activities","volume":"173","author":"Vargas-Mun\u00e9var","year":"2024","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2026.119490_bib58","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijpddr.2023.05.001","article-title":"vitro activity and mechanism of cell death induction of cyanomethyl vinyl ethers derivatives against Trypanosoma cruzi","volume":"22","author":"Bethencourt-Estrella","year":"2023","journal-title":"Int J. Parasitol. Drugs Drug Resist"},{"issue":"2","key":"10.1016\/j.biopha.2026.119490_bib59","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/microorganisms13020220","article-title":"Molecular identification and drug susceptibility of Leishmania spp. clinical isolates collected from two regions of Oaxaca, Mexico","volume":"13","author":"Moreno-Rodr\u00edguez","year":"2025","journal-title":"Microorganisms"},{"issue":"2","key":"10.1016\/j.biopha.2026.119490_bib60","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1590\/S0074-02762010000200022","article-title":"In vitro and in vivo experimental models for drug screening and development for Chagas disease","volume":"105","author":"Romanha","year":"2010","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"16","key":"10.1016\/j.biopha.2026.119490_bib61","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.3390\/molecules29163796","article-title":"Molecular docking-based virtual screening of FDA-approved drugs using trypanothione reductase identified new trypanocidal agents","volume":"29","author":"G\u00f3mez-Escobedo","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2026.119490_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.907631","article-title":"A mouse model of ulcerative cutaneous Leishmaniasis by Leishmania (Viannia) panamensis to investigate infection, pathogenesis, immunity, and therapeutics","volume":"13","author":"Mu\u00f1oz-Durango","year":"2022","journal-title":"Front. Microbiol"},{"issue":"1","key":"10.1016\/j.biopha.2026.119490_bib63","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00767-21","article-title":"New insights into the mechanism of action of the cyclopal-ladated complex (CP2) in Leishmania: calcium dysregulation, mitochondrial dysfunction, and cell death","volume":"66","author":"Vel\u00e1squez","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.biopha.2026.119490_bib64","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3390\/ijms25010659","article-title":"haracterization of the effect of N-(2-methoxyphenyl)-1-methyl-1H-benzimidazol-2-amine, compound 8, against Leishmania mexicana and its in vivo leishmanicidal activity","volume":"25","author":"Nieto-Meneses","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119490_bib65","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.biopha.2017.08.096","article-title":"vivo antileishmanial activity and histopathological evaluation in Leishmania infantum infected hamsters after treatment with a furoxan derivative","volume":"95","author":"de Almeida","year":"2017","journal-title":"Biomed. Pharm."},{"issue":"19","key":"10.1016\/j.biopha.2026.119490_bib66","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.3390\/molecules29194652","article-title":"Quinoxaline 1,4-di-N-oxide derivatives as new antinocardial agents","volume":"29","author":"Palos","year":"2024","journal-title":"Molecules"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226005263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226005263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:45:19Z","timestamp":1794476719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226005263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":66,"alternative-id":["S0753332226005263"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119490","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of 4-carboxylate-1,2,3-triazine 1-oxide, their 1,2,3-triazine, and the 3,6-dihydro analogs, as new agents against Chagas diseases and Leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119490"}}